The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

ETX Insider Trading

Insider Ownership Percentage: 59.47%
Insider Buying (Last 12 Months): £15,004.71
Insider Selling (Last 12 Months): GBX 0

e-therapeutics Insider Trading History Chart

This chart shows the insider buying and selling history at e-therapeutics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

e-therapeutics Share Price & Price History

Current Price: GBX 17.53
Price Change: Price Increase of +0.5 (2.94%)
As of 05/30/2023 06:08 PM ET

This chart shows the closing price history over time for ETX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>

e-therapeutics Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
1/4/2023Trevor Mervyn JonesInsiderBuy44,350GBX 17£7,539.50
7/4/2022Trevor Mervyn JonesInsiderBuy43,913GBX 17£7,465.21
10/26/2021Ali MortazaviInsiderBuy275,000GBX 37£101,750
1/4/2021Trevor Mervyn JonesInsiderBuy33,417GBX 16£5,346.72
7/14/2020Trevor Mervyn JonesInsiderBuy32,185GBX 17£5,471.45
See Full Table
3 Potential Sky-High Performers
Want to join a small community of investors looking for the next big winners in 2023?

These 3 Stocks are potential sky-high performers you should be watching heading into Monday.

Click Here for Names & Ticker Symbols.
>>>

SEC Filings (Institutional Ownership Changes) for e-therapeutics (LON:ETX)

28.94% of e-therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

e-therapeutics logo
e-Therapeutics plc engages in drug discovery research activities in the United Kingdom. Its computational platform provides in silico screens generate predictions on compounds and/or targets that can have a significant perturbative effect on the biology of interest, captured by its network models, as well as developing RNAi platform for highly specific gene silencing. The company was incorporated in 2001 and is based in London, the United Kingdom.
Read More on e-therapeutics

Today's Range

Now: GBX 17.53
Low: 17.49
High: 20.01

50 Day Range

MA: GBX 13.58
Low: 10.91
High: 17.03

52 Week Range

Now: GBX 17.53
Low: 10.05
High: 23.86

Volume

615,896 shs

Average Volume

173,531 shs

Market Capitalization

£102.11 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.47

Who are the company insiders with the largest holdings of e-therapeutics?

e-therapeutics' top insider investors include:
  1. Ali Mortazavi (Insider)
  2. Trevor Mervyn Jones (Insider)
Learn More about top insider investors at e-therapeutics.
The Ultimate Passive Income Play
The #1 income play for 2023 is NOT a stock, bond or private company... Rather, it's a little-known alternative investment that could hand you big monthly income from oil and gas. 

Find Out What It Is Right Here.
>>>